Fragment-based identification of Hsp90 inhibitors.
Barker, J.J., Barker, O., Boggio, R., Chauhan, V., Cheng, R.K., Corden, V., Courtney, S.M., Edwards, N., Falque, V.M., Fusar, F., Gardiner, M., Hamelin, E.M., Hesterkamp, T., Ichihara, O., Jones, R.S., Mather, O., Mercurio, C., Minucci, S., Montalbetti, C.A., Muller, A., Patel, D., Phillips, B.G., Varasi, M., Whittaker, M., Winkler, D., Yarnold, C.J.(2009) ChemMedChem 4: 963-966
- PubMed: 19301319 
- DOI: https://doi.org/10.1002/cmdc.200900011
- Primary Citation of Related Structures:  
3FT5, 3FT8 - PubMed Abstract: 
Heat shock protein 90 (Hsp90) plays a key role in stress response and protection of the cell against the effects of mutation. Herein we report the identification of an Hsp90 inhibitor identified by fragment screening using a high-concentration biochemical assay, as well as its optimisation by in silico searching coupled with a structure-based drug design (SBDD) approach.
Organizational Affiliation: 
Evotec, 114 Milton Park, Abingdon, Oxfordshire, OX10 4SA UK.